Biomea Fusion to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Company Overview - Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing oral covalent small molecules aimed at treating diabetes, obesity, and genetically defined cancers [1][3] - The company utilizes its proprietary FUSION™ System to design and develop a pipeline of next-generation covalent-binding small-molecule medicines [3] Upcoming Events - Thomas Butler, the CEO and Chairman of the Board, will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025, at 1:30 PM Pacific Time / 4:30 PM Eastern Time [1] - Biomea's management team will also host one-on-one meetings throughout the conference, which runs from January 13 to January 16, 2025 [1] Presentation Access - A live audio webcast of the presentation will be available on Biomea's website, with a replay accessible after the live event [2]